Shares of Depomed Inc (NASDAQ:DEPO) decreased -1.07% and closed at $24.09 after opening 24.28 with the overall traded volume of 528,224.00 shares. The company’s Market capitalization reached to $1.46 billion, $61.37 million outstanding shares. Its low price was $24.00 and highest price was $24.42. The Distance from 50 day Simple moving average was 6.95% and Distance from 200 day Simple moving average 29.76%.The EPS is -1.22.
Depomed Inc (DEPO) reported financial results and highlighted operational achievements for the quarter ended June 30, 2016.
Second quarter 2016 revenues were $117 million, compared to $95 million for second quarter of 2015, a 23% increase
Second quarter NUCYNTA® franchise revenue $72 million, compared to $57 million for second quarter of 2015, a 27% increase
Quarterly net loss of ($10.5) million or ($0.17) per share
Quarterly non-GAAP adjusted earnings of $19.8 million, or $0.27 per share
Quarterly non-GAAP adjusted EBITDA of $42.3 million
Shares of Amsurg Corp (NASDAQ:AMSG) decreased -1.26% and closed at $64.89 after opening 66.00 with the overall traded volume of 522,429.00 shares. The company’s Market capitalization reached to $3.51 billion, $54.81 million outstanding shares. Its low price was $64.73 and highest price was $66.13. The Distance from 50 day Simple moving average was -1.53% and Distance from 200 day Simple moving average was -10.28%. The EPS is 3.15.
Amsurg Corp (AMSG) and Envision Healthcare Holdings, Inc. (Envision) (EVHC) announced the composition of the Board of Directors of the newly formed Envision Healthcare Corporation following completion of the merger. In addition, both companies will hold their separate special meetings of shareholders on Monday, November 28, 2016 to vote on the merger of Envision and AMSURG.
The composition of the combined company’s Board of Directors and date of the special meetings were included in an amended preliminary joint proxy statement/prospectus that was filed with the U.S Securities and Exchange Commission on Friday, October 7, 2016, by the registrant “New Amethyst Corp.” New Amethyst Corp. will be renamed Envision Healthcare Corporation upon completion of the merger.